Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling

DNA 损伤和检查点信号转导中赖氨酸甲基化的结构生物学

基本信息

  • 批准号:
    7759525
  • 负责人:
  • 金额:
    $ 31.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2013-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term objective is to help decipher the mechanism of DNA double-strand break (DSB) repair, a process indispensable in maintaining genomic stability in all organisms, and an important barrier to cancer in higher eukaryotes. Reversible site-specific post-translational modifications of histone and non-histone proteins are essential for the DNA repair machinery to assemble at sites of DNA DSBs and to the concomitant checkpoint activation leading to cell cycle arrest or apoptosis, but how these modifications contribute to the DNA damage response is poorly understood. Our proposed research focuses on understanding the role of lysine methylation in DNA DSB and cell cycle checkpoint signaling. We will probe several molecular interactions driven by the methylation of histone H4 at lysine 20 (H4-K20) and p53 at lysine 370 (p53-K370), and their possible synergistic coupling to other post-translational modifications (e.g. phosphorylated histone H2AX). In particular, we will study the interactions of methylated histone H4-K20 and methylated p53-K370 with human proteins 53BP1, JMJD2A and PHF20. 53BP1 is a key transducer of the cell response to DNA DSBs that participates in the assembly of DNA repair proteins and in checkpoint activation regulated by p53. JMJD2A is a histone demethylase whose function is linked to p53-dependent DNA damage-induced apoptosis. PHF20 is a component of the MLL1/MOF histone acetyltransferase complex that acetylates histone H4 in a p53 dependent manner in connection to DNA damage. For each study, we will apply a combination of biophysical experiments centered on nuclear magnetic resonance (NMR) spectroscopy and crystallographic three-dimensional (3D) structure determination of selected domains in complex with their associated targets. In Aim1, we will test the hypothesis that 53BP1 simultaneously recognizes methylated H4-K20 and phosphorylated histone H2AX using tandem tudor and tandem BRCT domains, respectively. This dual binding mode would explain how 53BP1 is recruited to DNA damage sites. In Aims 2 and 3, we will test the hypotheses that methylation of p53 at lysine 370 triggers a tight interaction of p53 with 53BP1 and JMJD2A, preventing p53 from binding DNA. This would provide a mechanism for the known inhibition of p53 transcriptional activity by methylation of lysine 370. In Aim 4, we have identified a new motif in PHF20 that we call disulfide cross-linked tudor dimer. This tudor domain is found in tandem with an MBT domain. We will characterize the tudor, MBT and tandem MBT-tudor domains of PHF20 in complex with methylated H4-K20 and p53-K370 peptides. Our structural and interaction studies at the atomic level will be the basis for informed design of in vivo experiments that will elevate our knowledge of DNA DSB signaling and repair. Alteration of histone H4 methylation at Lys20 is a hallmark of human tumor cells and mutation of p53 occurs in about 50% of human cancers. In the long term, our studies involving methylated histone H4 and p53 may help control the DNA damage response therapeutically for the prevention and treatment of cancer. PUBLIC HEALTH RELEVANCE The proposed studies will contribute to the elucidation of fundamental cellular processes involved in detecting and repairing DNA double-strand breaks, one of the most harmful types of DNA damage. The work has relevance to public health because by understanding the mechanisms of these important processes, we may be able to find ways to prevent and treat human malignancies, particularly cancer.
描述(申请人提供):我们的长期目标是帮助破译DNA双链断裂(DSB)修复的机制,DSB修复是维持所有生物基因组稳定所必需的过程,也是高等真核生物癌症的重要屏障。组蛋白和非组蛋白的可逆组蛋白翻译后修饰对于DNA修复机制在DNA DSB位点组装以及伴随而来的检查点激活导致细胞周期停滞或凋亡是必不可少的,但这些修饰如何影响DNA损伤反应尚不清楚。我们的研究重点是了解赖氨酸甲基化在DNA DSB和细胞周期检查点信号中的作用。我们将探索组蛋白H4在赖氨酸20位(H4-K20)和p53在赖氨酸370位(P53-K370)甲基化所驱动的几个分子相互作用,以及它们与其他翻译后修饰(例如磷酸化组蛋白H_2AX)可能的协同偶联。特别是,我们将研究甲基化的组蛋白H4-K20和甲基化的P53-K370与人蛋白53BP1、JMJD2A和PHF20的相互作用。53BP1是细胞对DNA双链断裂反应的关键转导分子,参与DNA修复蛋白的组装和受P53调控的检查点激活。JMJD2A是一种组蛋白去甲基酶,其功能与P53依赖的DNA损伤诱导的细胞凋亡有关。PHF20是MLL1/MOF组蛋白乙酰转移酶复合体的一个组成部分,它以p53依赖的方式乙酰化组蛋白H4,与DNA损伤有关。对于每项研究,我们将应用以核磁共振(核磁共振)光谱为中心的生物物理实验和选定结构域及其相关目标的结晶学三维(3D)结构测定的组合。在Aim1中,我们将检验53BP1分别使用串联Tudor和串联BRCT结构域同时识别甲基化的H4-K20和磷酸化组蛋白H2 AX的假设。这种双重结合模式可以解释53BP1是如何被招募到DNA损伤部位的。在目标2和3中,我们将测试假设,即P53赖氨酸370的甲基化触发P53与53BP1和JMJD2A的紧密相互作用,阻止P53结合DNA。这将为已知的通过赖氨酸370甲基化抑制P53转录活性提供机制。在目标4中,我们在PHF20中确定了一个新的基序,我们称之为二硫键交联型都铎二聚体。该都铎结构域与MBT结构域一起被发现。我们将在与甲基化的H4-K20和P53-K370肽的复合体中鉴定PHF20的Tudor、MBT和串联的MBT-Tudor结构域。我们在原子水平上的结构和相互作用研究将是体内实验知情设计的基础,这将提高我们对DNA DSB信号和修复的知识。组蛋白H4在Lys20的甲基化改变是人类肿瘤细胞的一个标志,而P53的突变发生在大约50%的人类癌症中。从长远来看,我们涉及甲基化的组蛋白H4和P53的研究可能有助于控制DNA损伤反应,用于癌症的预防和治疗。公共卫生相关性拟议的研究将有助于阐明检测和修复DNA双链断裂所涉及的基本细胞过程,DNA双链断裂是最有害的DNA损伤类型之一。这项工作与公众健康相关,因为通过了解这些重要过程的机制,我们可能能够找到预防和治疗人类恶性肿瘤的方法,特别是癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Georges Mer其他文献

Georges Mer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Georges Mer', 18)}}的其他基金

Structural biology of DNA damage response in chromatin
染色质 DNA 损伤反应的结构生物学
  • 批准号:
    10360611
  • 财政年份:
    2020
  • 资助金额:
    $ 31.35万
  • 项目类别:
Structural biology of DNA damage response in chromatin
染色质 DNA 损伤反应的结构生物学
  • 批准号:
    10569017
  • 财政年份:
    2020
  • 资助金额:
    $ 31.35万
  • 项目类别:
Structural basis of RNF168-mediated ubiquitin signaling at chromosomal DNA breaks
染色体 DNA 断裂时 RNF168 介导的泛素信号传导的结构基础
  • 批准号:
    9147614
  • 财政年份:
    2015
  • 资助金额:
    $ 31.35万
  • 项目类别:
Post-translational Modifications in DNA Damage Response: a Structural Perspective
DNA 损伤反应的翻译后修饰:结构视角
  • 批准号:
    9178635
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
Post-translational Modifications in DNA Damage Response: a Structural Perspective
DNA 损伤反应的翻译后修饰:结构视角
  • 批准号:
    8627747
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
Post-translational Modifications in DNA Damage Response: a Structural Perspective
DNA 损伤反应的翻译后修饰:结构视角
  • 批准号:
    8969666
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
Post-translational Modifications in DNA Damage Response: a Structural Perspective
DNA 损伤反应的翻译后修饰:结构视角
  • 批准号:
    8788387
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling
DNA 损伤和检查点信号转导中赖氨酸甲基化的结构生物学
  • 批准号:
    8016109
  • 财政年份:
    2008
  • 资助金额:
    $ 31.35万
  • 项目类别:
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling
DNA 损伤和检查点信号转导中赖氨酸甲基化的结构生物学
  • 批准号:
    8212403
  • 财政年份:
    2008
  • 资助金额:
    $ 31.35万
  • 项目类别:
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling
DNA 损伤和检查点信号转导中赖氨酸甲基化的结构生物学
  • 批准号:
    7586836
  • 财政年份:
    2008
  • 资助金额:
    $ 31.35万
  • 项目类别:

相似海外基金

Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    8704723
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    9318170
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    9115467
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
Engineering High-Affinity T Cell Receptors Against Cancer Antigens
设计针对癌症抗原的高亲和力 T 细胞受体
  • 批准号:
    8596188
  • 财政年份:
    2013
  • 资助金额:
    $ 31.35万
  • 项目类别:
CD4+ T cell affinity for self and foreign antigens in the CNS
CD4 T 细胞对 CNS 中自身和外来抗原的亲和力
  • 批准号:
    8068331
  • 财政年份:
    2010
  • 资助金额:
    $ 31.35万
  • 项目类别:
CD4+ T cell affinity for self and foreign antigens in the CNS
CD4 T 细胞对 CNS 中自身和外来抗原的亲和力
  • 批准号:
    7991226
  • 财政年份:
    2010
  • 资助金额:
    $ 31.35万
  • 项目类别:
CD4+ T cell affinity for self and foreign antigens in the CNS
CD4 T 细胞对 CNS 中自身和外来抗原的亲和力
  • 批准号:
    8668170
  • 财政年份:
    2010
  • 资助金额:
    $ 31.35万
  • 项目类别:
CD4+ T cell affinity for self and foreign antigens in the CNS
CD4 T 细胞对 CNS 中自身和外来抗原的亲和力
  • 批准号:
    8471796
  • 财政年份:
    2010
  • 资助金额:
    $ 31.35万
  • 项目类别:
CD4+ T cell affinity for self and foreign antigens in the CNS
CD4 T 细胞对 CNS 中自身和外来抗原的亲和力
  • 批准号:
    8269691
  • 财政年份:
    2010
  • 资助金额:
    $ 31.35万
  • 项目类别:
IGG AFFINITY FOR BACTERIAL ANTIGENS AND PHAGOCYTIC CELLS
IGG 对细菌抗原和吞噬细胞的亲和力
  • 批准号:
    3445602
  • 财政年份:
    1986
  • 资助金额:
    $ 31.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了